Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  Poolsup, Nalinee ^b   Suksomboon, Naeti ^a   Kyaw, Aye Mon ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SILPAKORN UNIVERSITY   (Thailand)

Author keywords

Continuous glucose monitoring (CGM); Self monitoring of blood glucose; SMBG; Systematic review; T1DM; T2DM; Type 1 diabetes; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; BIBLIOGRAPHIC DATABASE; BLOOD GLUCOSE MONITORING; CINAHL; COCHRANE LIBRARY; CONTINUOUS GLUCOSE MONITORING; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH CARE PERSONNEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTERNAL VALIDITY; LIFESTYLE MODIFICATION; MEDLINE; META ANALYSIS; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PRIORITY JOURNAL; QUALITY CONTROL; SCOPUS; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); WEB OF SCIENCE;

EID: 84880335131     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-39     Document Type: Article

References (46)

1. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Whiting DR, Guariguata L, Weil C, Shaw J, Diabetes Res Clin Pract 2011 94 3 311 321 10.1016/j.diabres.2011.10.029 22079683
2. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Wild S, Roglic G, Green A, Sicree R, King H, Diabetes Care 2004 27 5 1047 1053 10.2337/diacare.27.5.1047 15111519 (Pubitemid 38579764)
3. International Diabetes Federation. Facts & figures: prevalence 2006 http://www.idf.org/diabetesatlas/5e/what-is-diabetes 22384075
4. Is glycemic control improving in U.S. adults? Hoerger TJ, Segel JE, Gregg EW, Saaddine JB, Diabetes Care 2008 31 81 86 10.2337/dc08-1303 17934153
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 Diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group, Lancet 1998 652 837 853
6. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. The Diabetes Control Complications Research Group, N Engl J Med 1993 329 977 986 8366922
7. Frequency of severe hypoglycaemia in patients with type 1 diabetes with impaired awareness of hypoglycaemia. Gold EA, Mac Leod KM, Frier B, Diabetes Care 1994 17 697 703 10.2337/diacare.17.7.697 7924780 (Pubitemid 24198035)
8. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1996-2004). Sarol JN, Nicodemus NA, Tan KM, Grava MB, Curr Med Res Opin 2005 21 2 173 184 10.1185/030079904X20286 15801988 (Pubitemid 40469894)
9. Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: An update. Poolsup N, Suksomboon N, Rattanasookchit S, Diabetes Techno Ther 2009 11 12 775 782 10.1089/dia.2009.0091
10. High frequency of unrecognized hypoglycaemias in patients with type 2 diabetes is discovered by continuous glucose monitoring. Weber KK, Lohmann T, Busch K, Donati-Hirsch I, Riel R, Exp Clin Endocrinol Diabetes 2007 115 491 494 10.1055/s-2007-984452 17853331 (Pubitemid 350056760)
11. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Boland E, Monsod T, Delucia M, et al. Diabetes Care 2001 24 11 1858 1862 10.2337/diacare.24.11.1858 11679447 (Pubitemid 33716491)
12. Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. MacGowan K, Thomas W, Moran A, Diabetes Care 2002 25 9 1499 1503 10.2337/diacare.25.9.1499 12196417 (Pubitemid 41071101)
13. Continuous real-time glucose monitoring systems: time for a closer look. Kerr D, Fayers K, Pract Diab Int 2008 25 1 37 41 10.1002/pdi.1197
14. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. Bergenstal RM, Tamborlane WV, Ahmann A, et al. N Eng J Med 2010 363 311 320 10.1056/NEJMoa1002853
15. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Battelino T, Congret I, Olsen B, et al. Diabetologia 2012 55 12 3155 3162 10.1007/s00125-012-2708-9 22965294
16. Continuous glucose monitoring system in children with type 1 diabetes mellitus: a systematic review and meta-analysis. Golicki DT, Golicka D, Groele L, Pankowska E, Diabetologia 2008 51 233 240 10.1007/s00125-007-0884-9 18060380
17. Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: A systematic Review and meta-analysis of randomized trial. Gandhi GY, Kovalaske M, Kudva Y, et al. J Diabetes Sci Technol 2011 5 4 952 963 21880239
18. 2009 updated method guidelines for systematic reviews in the cochrane back review group. Furlan AD, Pennick V, Bombardier C, Tulder MV, Spine 2009 34 18 1929 1941 10.1097/BRS.0b013e3181b1c99f 19680101
19. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Control Clin Trials 1996 17 1 1 12 10.1016/0197-2456(95) 00134-4 8721797 (Pubitemid 26120810)
20. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Bouter LM, Knipschild PG, J Clin Epidemiol 1998 51 1235 1241 10.1016/S0895-4356(98)00131-0 10086815 (Pubitemid 29009523)
21. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. Deeks JJ, Altman DG, Bradburn MJ, Systematic reviews in health care: meta-analysis in context United Kingdom: BMJ publishing group, Egger M, Smith GD, Altman DG, 2 2001 289 290
22. Bias in meta-analysis detected by a simple, graphical test. Egger M, Davey SG, Schneider M, Minder C, BMJ 1997 315 629 634 10.1136/bmj.315.7109.629 9310563 (Pubitemid 27387172)
23. Results of a randomized controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycemic control in children and adolescents with type 1 diabetes. Deiss D, Hartmann R, Schmidt J, Kordonouri O, Exp Clin Endocrinol Diabetes 2006 114 63 67 10.1055/s-2006-923887 16570235
24. Continuous subtaneous glucose monitoirng in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Lagarde WH, Barrows FP, Davenport ML, Kang M, et al. Paediatric Diabetes 2006 7 159 164 10.1111/j.1399-543X.2006.00162.x
25. Continuous glucose monitoring-guided insulin adjustment in children and adolescents on near-physiological insulin regimens. Yates K, Milton AH, Dear K, Ambler G, Diabetes Care 2006 29 7 1512 1517 10.2337/dc05-2315 16801571 (Pubitemid 44127573)
26. Continuous glucose monitoring and intensive treatment of type 1 diabetes. The juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, N Engl J Med 2008 359 1464 1476 18779236
27. Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment. Kordonouri O, Pankowska E, Rami B, et al. Diabetologia 2010 53 2487 2495 10.1007/s00125-010-1878-6 20711715
28. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Chase HP, Kim LM, Owen SL, Mackenzie TA, Klingersmith GJ, Murtfeld R, Garg SK, Pediatrics 2001 107 222 226 10.1542/peds.107.2.222 11158450 (Pubitemid 32121233)
29. Short-term use of continuous glucose monitoring system adds to glycemic control in young type 1 diabetes mellitus patients in the long run: a clinical trial. Bukara-Radujkovic G, Zdravkovic D, Lakic S, Vojnosanit Pregl 2011 68 8 650 654 10.2298/VSP1108650B 21991787
30. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to < 10 years. Mauras N, Beck R, Xing D, et al. Diabetes Care 2012 35 204 210 10.2337/dc11-1746 22210571
31. Use of a real time continuouse glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Yoo HJ, An HG, Park SY, et al. Diabetes Res Clin Pract 2008 82 73 79 10.1016/j.diabres.2008.06.015 18701183
32. Multicentre, randomized, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetic patients. Cosson E, Hamo-Tchatchouang E, Dufaitre-Patouraux L, et al. Diabetes Metab 2009 35 4 312 318 10.1016/j.diabet.2009.02.006 19560388
33. Continuous glucose monitoring improves physical activity behaviors of individuals with type 2 diabetes: a randomized clinical trial. Allen NA, Fain JA, Braun B, Chipkin SR, Diabetes Res Clin Pract 2008 80 371 379 10.1016/j.diabres.2008.01.006 18304674
34. The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus. Ehrhardt NM, Chellappa M, Walker MS, Fonda SJ, Vigersky RA, J Diabetes Sci Technol 2011 5 3 668 675 21722581
35. Short- and Long- term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM, Diabetes Care 2012 35 32 38 10.2337/dc11-1438 22100963
36. American Academy of Paediatric, Definition of age group terminology http://www.aap.org/en-us/Pages/Default.aspx
37. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Ludvigsson J, Hanas R, Pediatrics 2003 111 5 pt 1 933 938 12728068 (Pubitemid 36542603)
38. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes. Wojciechowski P, Rys P, Lipowska A, et al. Pol Arch Med Wewn 2011 121 10 334 340
39. Continuous glucose monitoring systems for type 1 diabetes mellitus. Langendam M, Luijf YM, Hooft L, DeVries JH, Mudde AH, Scholten RJPM, Cochrane Database Syst Rev 2012 2 1 135
40. Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials. DeFronzo RA, Stonehouse AH, Han J, Wintle ME, Diabet Med 2010 27 3 309 317 10.1111/j.1464-5491.2010.02941.x 20536494
41. Joslin Diabetes Center & Joslin Clinic, Clinical guidelines for adults with diabetes [online]. http://www.joslin.org/info/joslin-clinical- guidelines.html
42. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. Krolewski AS, Laffel LM, Krolewski M, Quinn M, Warram JH, N Engl J Med 1995 332 19 1251 1255 10.1056/ NEJM199505113321902 7708068
43. Family conflict, adherence, and glycaemic control in youth with short duration Type 1 diabetes. Anderson BJ, Vangsness L, Connell A, Butler D, Goebel-Fabbri A, Laffel LMB, Diabet Med 2002 19 635 642 10.1046/j.1464-5491. 2002.00752.x 12147143 (Pubitemid 34985163)
44. The transition to young adulthood in youth with type 1 diabetes on intensive treatment. Insabella G, Grey M, Knafl G, Tamborlane W, Pediatr Diabetes 2007 8 228 234 10.1111/j.1399-5448.2007.00266.x 17659065 (Pubitemid 47103763)
45. Standards of medical care in diabetes-2006. American Diabetes Association, Diabetes Care 2006 29 Suppl 1 4 S42 16373931
46. Mechanistic studies of lifestyle interventions in type 2 diabetes. Mitra A, Dewanjee D, Dey B, World J Diabetes 2012 3 12 201 207 10.4239/wjd.v3.i12.201 23301122